Breaking News Instant updates and real-time market news.

AGIO

Agios Pharmaceuticals

$40.93

0.81 (2.02%)

18:40
12/08/19
12/08
18:40
12/08/19
18:40

Agios' initial mitapivat beta thal update 'very encouraging,' says Piper Jaffray

Piper Jaffray analyst Tyler Van Buren said the initial 88% response rate reported by Agios Pharmaceuticals in its study of mitapivat in non-transfusion dependent beta thal patients was "very encouraging." Though it is early, mitapivat "now appears to be a competitive oral agent for beta thal" and the probability of success in sickle cell disease, which could result in a value five times greater than beta thal, has now increased as well, Van Buren tells investors. He reiterated his Overweight rating on Agios shares following the company's ASH meeting presentation.

  • 09

    Dec

  • 13

    Dec

AGIO Agios Pharmaceuticals
$40.93

0.81 (2.02%)

10/28/19
PIPR
10/28/19
NO CHANGE
Target $70
PIPR
Overweight
Agios Pharmaceuticals price target lowered to $70 from $80 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren lowered his price target for Agios Pharmaceuticals to $70 from $80 after initial clinical data from AG-270's methylthioadenosine phosphorylase program yielded low monotherapy activity, as expected. The analyst we believes it is prudent to remove AG-270 from his model. However, he keeps an Overweight rating on Agios saying the shares "are at a floor and that significant value can still be created" from mitapivat, DHODH, or eventually methylthioadenosine phosphorylase.
11/05/19
SBSH
11/05/19
NO CHANGE
Target $64
SBSH
Buy
Agios Pharmaceuticals price target lowered to $64 from $80 at Citi
Citi analyst Mohit Bansal lowered his price target for Agios Pharmaceuticals to $64 from $80 saying the company's announcement, based on the FDA feedback, to wait for overall survival data for filing makes him less confident in the cholangio approval. However, the analyst does not think the Street was giving much credit to cholangio. He keeps a Buy rating on Agios.
11/24/19
PIPR
11/24/19
NO CHANGE
PIPR
Overweight
Piper Jaffray reiterates Overweight on Agios after 'encouraging' SNO update
Piper Jaffray analyst Tyler Van Buren reiterated an Overweight rating and $70 price target on Agios following the company's "encouraging" IDH/glioma update at the Society for Neuro-Oncology, or SNO. The analyst believes the perioperative results are "promising" given the response and disease control rates observed, and believes the "high DCR suggests that IDH inhibition is proving a meaningful, durable treatment benefit." Van Buren said that this could ultimately become a $500M opportunity that is not currently modeled.
11/26/19
CANT
11/26/19
INITIATION
Target $64
CANT
Overweight
Agios Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young initiated coverage of Agios Pharmaceuticals with an Overweight rating and $64 price target. Although shares were under pressure in 2019, there are catalysts on the horizon and overhangs lifted like financing "that should clear the way for 2020 outperformance," Young tells investors in a research note. She believes Agios has a "robust R&D engine" focused on cellular metabolism and precision medicine for cancer and rare genetic diseases.

TODAY'S FREE FLY STORIES

DIS

Disney

$143.99

0.46 (0.32%)

12:33
01/22/20
01/22
12:33
01/22/20
12:33
Hot Stocks
Scopely acquires FoxNext Games, Cold Iron Studios from Disney »

Scopely and The Walt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

, PUGOY

Peugeot

$0.00

(0.00%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Periodicals
Fiat Chrysler CEO says PSA deal talks 'progressing really well,' Reuters says »

Fiat Chrysler (FCAU) CEO…

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

PUGOY

Peugeot

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.66

0.345 (6.49%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Conference/Events
The Executives' Club of Chicago to hold a luncheon meeting »

The Executives' Club…

SRPT

Sarepta

$121.03

-1.65 (-1.34%)

12:24
01/22/20
01/22
12:24
01/22/20
12:24
Periodicals
New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says »

New documents released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$1.96

0.04 (2.08%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Hot Stocks
Proteostasis to present data from organoid study in CF treatment »

Proteostasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNA

Moderna

$21.97

1 (4.77%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Recommendations
Moderna analyst commentary  »

Moderna mRNA technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/22/20
01/22
12:15
01/22/20
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude hit…

TWLO

Twilio

$119.62

0.47 (0.39%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
Periodicals
Breaking Periodicals news story on Twilio »

Hedgeye adds Twilio to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 24

    Feb

NFLX

Netflix

$332.00

-6.24 (-1.84%)

, IBM

IBM

$143.22

4.07 (2.92%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rebounding…

NFLX

Netflix

$332.00

-6.24 (-1.84%)

IBM

IBM

$143.22

4.07 (2.92%)

AAPL

Apple

$318.43

2.04 (0.64%)

ETN

Eaton

$97.23

2.72 (2.88%)

ABT

Abbott

$92.33

2.57 (2.86%)

NAVI

Navient

$15.02

1.16 (8.37%)

ARNC

Arconic

$28.60

-0.795 (-2.71%)

FCEL

FuelCell

$2.14

-0.735 (-25.61%)

NTRS

Northern Trust

$102.32

-6.35 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 04

    Feb

NTDOY

Nintendo

$0.00

(0.00%)

12:09
01/22/20
01/22
12:09
01/22/20
12:09
Periodicals
Judge says iLife's patent suit against Nintendo not valid, Verge says »

Federal Judge Barbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WILC

G. Willi-Food

$12.22

-0.21 (-1.69%)

12:06
01/22/20
01/22
12:06
01/22/20
12:06
Hot Stocks
G. Willi-Food CEO Michael Luboschitz to resign for personal reasons »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.41

0.77 (2.51%)

12:05
01/22/20
01/22
12:05
01/22/20
12:05
Options
Elanco Animal Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 23

    Jan

HUYA

Huya

$18.73

-1.75 (-8.54%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Huya falls -8.5% »

Huya is down -8.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMRE

Costamare

$9.01

-1.34 (-12.95%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Costamare falls -12.9% »

Costamare is down -12.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$7.28

-0.71 (-8.89%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Cango falls -9.3% »

Cango is down -9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFT

OneConnect

$15.17

1.2 (8.59%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
OneConnect rises 8.5% »

OneConnect is up 8.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Periodicals
Bombardier subway cars returning to service this week in NYC, Reuters says »

Bombardier subway cars…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

FSB

Franklin Financial Network

$38.25

4.13 (12.10%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Franklin Financial Network rises 12.6% »

Franklin Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$4.88

0.73 (17.59%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Express rises 17.5% »

Express is up 17.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

BTI

British American Tobacco

$44.63

0.06 (0.13%)

11:56
01/22/20
01/22
11:56
01/22/20
11:56
Upgrade
British American Tobacco rating change  »

British American Tobacco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPR

Spirit AeroSystems

$64.32

-0.24 (-0.37%)

11:55
01/22/20
01/22
11:55
01/22/20
11:55
Options
Spirit AeroSystems put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HARL

Harleysville Savings Financial Corp

$0.00

(0.00%)

11:53
01/22/20
01/22
11:53
01/22/20
11:53
Earnings
Harleysville reports Q1 EPS 50c vs. 57c last year »

Q1 net income included a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.